Quarterly Result7 Aug 2026, 02:50 pm
iSERA Lifesciences Declares Unaudited Standalone Q1 FY27 Results
AI Summary
iSERA Lifesciences Ltd announced its unaudited standalone financial results for the quarter ended June 30, 2026. The Board of Directors met on August 7, 2026, to approve these results and the accompanying limited review report from the independent auditor. The company operates in a single segment, IT/ITES, as per Ind AS-108.
Key Highlights
- Unaudited standalone financial results for Q1 FY27 declared.
- Board of Directors approved the results on August 7, 2026.
- Independent auditor's limited review report also approved.
- Company operates in a single IT/ITES segment.
Price Impact
More from COVIDH
More in Quarterly Result